Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Healy, Daniel G
2006.
Case-control studies in the genomic era: a clinician's guide.
The Lancet Neurology,
Vol. 5,
Issue. 8,
p.
701.
Banks, William A.
Niehoff, Michael L.
Drago, Denise
and
Zatta, Paolo
2006.
Aluminum complexing enhances amyloid β protein penetration of blood–brain barrier.
Brain Research,
Vol. 1116,
Issue. 1,
p.
215.
Serkova, Natalie J
and
Niemann, Claus U
2006.
Pattern recognition and biomarker validation using quantitative1H-NMR-based metabolomics.
Expert Review of Molecular Diagnostics,
Vol. 6,
Issue. 5,
p.
717.
Schipper, Hyman M.
2007.
The role of biologic markers in the diagnosis of Alzheimer's disease.
Alzheimer's & Dementia,
Vol. 3,
Issue. 4,
p.
325.
Dumont, Debora
Noben, Jean‐Paul
Moreels, Marjan
Vanderlocht, Joris
Hellings, Niels
Vandenabeele, Frank
Lambrichts, Ivo
Stinissen, Piet
and
Robben, Johan
2007.
Characterization of mature rat oligodendrocytes: a proteomic approach.
Journal of Neurochemistry,
Vol. 102,
Issue. 2,
p.
562.
Formichi, P.
Parnetti, L.
Radi, E.
Cevenini, G.
Dotti, M. T.
and
Federico, A.
2008.
CSF levels of β‐amyloid 1‐42, tau and phosphorylated tau protein in CADASIL.
European Journal of Neurology,
Vol. 15,
Issue. 11,
p.
1252.
Nobili, Flavio
Frisoni, Giovanni B.
Portet, Florence
Verhey, Frans
Rodriguez, Guido
Caroli, Anna
Touchon, Jacques
Calvini, Piero
Morbelli, Silvia
De Carli, Fabrizio
Guerra, Ugo P.
Van de Pol, Laura A.
and
Visser, Pieter-Jelle
2008.
Brain SPECT in subtypes of mild cognitive impairment.
Journal of Neurology,
Vol. 255,
Issue. 9,
p.
1344.
Paraskevas, G. P.
Kapaki, E.
Papageorgiou, S. G.
Kalfakis, N.
Andreadou, E.
Zalonis, I.
and
Vassilopoulos, D.
2009.
CSF biomarker profile and diagnostic value in vascular dementia.
European Journal of Neurology,
Vol. 16,
Issue. 2,
p.
205.
Begum, Farhana
Zhu, Wenjun
Namaka, Michael P.
and
Frost, Emma E.
2010.
A novel decalcification method for adult rodent bone for histological analysis of peripheral–central nervous system connections.
Journal of Neuroscience Methods,
Vol. 187,
Issue. 1,
p.
59.
Jonsson, M.
Zetterberg, H.
Van Straaten, E.
Lind, K.
Syversen, S.
Edman, Å.
Blennow, K.
Rosengren, L.
Pantoni, L.
Inzitari, D.
and
Wallin, A.
2010.
Cerebrospinal fluid biomarkers of white matter lesions – cross‐sectional results from the LADIS study.
European Journal of Neurology,
Vol. 17,
Issue. 3,
p.
377.
Stefani, Alessandro
Brusa, Livia
Olivola, Enrica
Pierantozzi, Mariangela
and
Martorana, Alessandro
2012.
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
Journal of Neural Transmission,
Vol. 119,
Issue. 7,
p.
861.
Liu, Bo
Tang, Yulan
Shen, Yuefei
Cen, Luan
and
Han, Min
2014.
Cerebrospinal Fluid τ Protein in Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia in Chinese population.
American Journal of Alzheimer's Disease & Other Dementiasr,
Vol. 29,
Issue. 2,
p.
116.
Bos, Isabelle
Verhey, Frans R.
Ramakers, Inez H.G.B.
Jacobs, Heidi I. L.
Soininen, Hilkka
Freund-Levi, Yvonne
Hampel, Harald
Tsolaki, Magda
Wallin, Åsa K.
van Buchem, Mark A.
Oleksik, Ania
Verbeek, Marcel M.
Olde Rikkert, Marcel
van der Flier, Wiesje M.
Scheltens, Philip
Aalten, Pauline
Visser, Pieter Jelle
and
Vos, Stephanie J. B.
2017.
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
Alzheimer's Research & Therapy,
Vol. 9,
Issue. 1,
Frantellizzi, Viviana
Pani, Arianna
Ricci, Maria
Locuratolo, Nicoletta
Fattapposta, Francesco
De Vincentis, Giuseppe
and
Pastori, Daniele
2020.
Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review.
Journal of Alzheimer's Disease,
Vol. 73,
Issue. 4,
p.
1279.
Wong, Fennie Choy Chin
Saffari, Seyed Ehsan
Yatawara, Chathuri
Ng, Kok Pin
and
Kandiah, Nagaendran
2021.
Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
Journal of Alzheimer's Disease,
Vol. 84,
Issue. 1,
p.
91.